Paul Briaud

Paul Briaud

Auto-generated profile, based on publicly available information

Paul Briaud

CIRI

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2019 in Scientific Reports
Verified
Journal Article
Open access
PBPaul Briaud
Paul Briaud
LCLaura Camus
Laura Camus
SBSylvère Bastien
Sylvère Bastien
ADAnne Doléans-Jordheim
Anne Doléans-Jordheim
FVFrançois Vandenesch
François Vandenesch
Karen MoreauKaren Moreau
Karen Moreau
Cystic fibrosis (CF) is the most common life-threatening genetic disease among Caucasians. CF patients suffer from chronic lung infections due to the presence of thick mucus, caused by cftr gene dysfunction. The two most commonly found bacteria in the mucus of CF patients are Staphylococcus aureus and Pseudomonas aeruginosa. It is well known that early-infecting P. aeruginosa strains produce anti-staphylococcal compounds and inhibit S. aureus growth. More recently, it has been shown that late-infecting P. aeruginosa strains develop commensal-like/coexistence interaction with S. aureus. The aim of this study was to decipher the impact of P. aeruginosa strains on S. aureus. RNA sequencing analysis showed 77 genes were specifically dysregulated in the context of competition and 140 genes in the context of coexistence in the presence of P. aeruginosa. In coexistence, genes encoding virulence factors and proteins involved in carbohydrates, lipids, nucleotides and amino acids metabolism were downregulated. On the contrary, several transporter family encoding genes were upregulated. In particular, several antibiotic pumps belonging to the Nor family were upregulated: tet38, norA and norC, leading to an increase in antibiotic resistance of S. aureus when exposed to tetracycline and ciprofloxacin and an enhanced internalization rate within epithelial pulmonary cells. This study shows that coexistence with P. aeruginosa affects the S. aureus transcriptome and virulence.

19 August 2020 in The ISME Journal
Verified
Journal Article
Closed access
PDF file
LCLaura Camus
Laura Camus
PBPaul Briaud
Paul Briaud
SBSylvère Bastien
Sylvère Bastien
SESylvie Elsen
Sylvie Elsen
ADAnne Doléans-Jordheim
Anne Doléans-Jordheim
Karen MoreauKaren Moreau
Karen Moreau
In the context of infection, Pseudomonas aeruginosa and Staphylococcus aureus are frequently co-isolated, particularly in cystic fibrosis (CF) patients. Within lungs, the two pathogens exhibit a range of competitive and coexisting interactions. In the present study, we explored the impact of S. aureus on the physiology of P. aeruginosa in the context of coexistence. Transcriptomic analyses showed that S. aureus significantly and specifically affects the expression of numerous genes involved in P. aeruginosa carbon and amino acid metabolism. In particular, 65% of the strains presented considerable overexpression of the genes involved in the acetoin catabolic (aco) pathway. We demonstrated that acetoin is (i) produced by clinical S. aureus strains, (ii) detected in sputa from CF patients and (iii) involved in P. aeruginosa’s aco system induction. Furthermore, acetoin is catabolized by P. aeruginosa, a metabolic process that improves the survival of both pathogens by providing a new carbon source for P. aeruginosa and avoiding the toxic accumulation of acetoin on S. aureus. Due to its beneficial effects on both bacteria, acetoin catabolism could testify to the establishment of trophic cooperation between S. aureus and P. aeruginosa in the CF lung environment, thus promoting their persistence.

3 June 2020 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
PBPaul Briaud
Paul Briaud
SBSylvère Bastien
Sylvère Bastien
LCLaura Camus
Laura Camus
MBMarie Boyadjian
Marie Boyadjian
PRPhilippe Reix
Philippe Reix
KMKaren Moreau
Karen Moreau
Staphylococcus aureus (SA) is the major colonizer of the lungs of cystic fibrosis (CF) patients during childhood and adolescence. As patients age, the prevalence of SA decreases and Pseudomonas aeruginosa (PA) becomes the major pathogen infecting adult lungs. Nonetheless, SA remains significant and patients harboring both SA and PA are frequently found in the worldwide cohort. The overall impact of co-infection remains controversial. Furthermore, co-infecting isolates may compete or coexist. The aim of this study was to analyse if co-infection and the coexistence of SA and PA could lead to worse clinical outcomes. The clinical and bacteriological data of 212 Lyon CF patients were collected retrospectively, and patients were ranked into three groups, SA only (n = 112), PA only (n = 48) or SA plus PA (n = 52). In addition, SA and PA isolates from co-infected patients were tested in vitro to define their interaction profile. Sixty five percent (n = 34) of SA/PA pairs coexist. Using univariate and multivariate analysis, we confirm that SA patients have a less severe clinical condition than others, and PA induces a poor outcome independently of the presence of SA. Regarding co-infection, no significant difference in clinical outcomes was observed between patients with coexisting pairs and patients with competitive pairs. However, when compared to SA mono-infected patients, patients with coexisting pair presented higher frequency and length of hospitalizations and more exacerbations. We suggest that coexistence between SA and PA may be an important step in the natural history of lung bacterial colonization within CF patients.

27 October 2021 in mSphere
Verified
Journal Article
Open access
PBPaul Briaud
Paul Briaud
AFAndrew Frey
Andrew Frey
EMEmily C. Marino
Emily C. Marino
RBRaeven A. Bastock
Raeven A. Bastock
RZRiley E. Zielinski
Riley E. Zielinski
RCRonan Carroll
Ronan Carroll
Extracellular vesicles (EVs) are lipid bilayer spheres that contain proteins, nucleic acids, and lipids secreted by bacteria. They are involved in Staphylococcus aureus infections, as they package virulence factors and deliver their contents inside host cells.

19 October 2022
Verified
Book Chapter
Closed access
PDF file
LCLaura Camus
Laura Camus
PBPaul Briaud
Paul Briaud
FVFrançois Vandenesch
François Vandenesch
ADAnne Doléans-Jordheim
Anne Doléans-Jordheim
Karen MoreauKaren Moreau
Karen Moreau

24 November 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
PBPaul Briaud
Paul Briaud
JBJessica Baude
Jessica Baude
SBSylvère Bastien
Sylvère Bastien
LCLaura Camus
Laura Camus
FVFrançois Vandenesch
François Vandenesch
Karen MoreauKaren Moreau
Karen Moreau
A novel efflux pump similar to Nor efflux pumps and designated as NorK was identified in Staphylococcus aureus . It contributes to norfloxacin resistance and presents a high level of expression in different strains. Its expression is not regulated by MgrA, unlike other genes of the nor gene family, suggesting that NorK could be important in the absence of expression of other nor genes.